Views - Page 23 - Lumanity

View Jun 11, 2020

Focusing on Professional Growth in 2020

View Jun 8, 2020

Differences between FDA COVID-19 Guidance for Alcohol-Based Hand Sanitizers and Monograph Hand Sanitizers Containing Alcohol

View Jun 4, 2020

FDA Requirements for Coronavirus Tests with At-home Specimen Collection

View Jun 2, 2020

FDA Announces New Changes to Permitted Marketing Status of OTC Monograph Drugs

View May 6, 2020

Finding Understanding in a World of Isolation and Containment

View Apr 28, 2020

Talc and Asbestos Defendants Should Monitor and Utilize Published Studies Linking Mesothelioma to Genomic Causes

View Apr 23, 2020

OTC Monograph Drug Reform Changes the Pharmaceutical Landscape

View Apr 8, 2020

Biopharmaceutical Launch Strategies: What You Need to Know in 2020

View Apr 1, 2020

BioPharma Dealmaking in the Time of Social Distancing

View Mar 24, 2020

Is Novartis’ RNA Therapeutic Inclisiran Poised to Displace PCSK9 Antibodies and Become the Next Blockbuster Lipid-Lowering Drug

View Mar 23, 2020

Using Genomics to Track the Global Spread of COVID19

View Feb 18, 2020

Innovation in a Buyer’s Market: Standing Out in an Increasingly Crowded and Diversified Cancer Treatment Algorithm

View Feb 16, 2020

Oncology 2020, the Coming Decade’s Visionary Advances – Part III

View Feb 12, 2020

Hit the Road Running, an Introduction to Publications

View Feb 7, 2020

FDA Antimicrobial Drugs Advisory Committee Meeting (AMDAC) Recommends Approval of FETROJA (cefiderocol lyophilized powder)

View Feb 5, 2020

CD19 and BCMA – “What if This Is As Good as It Gets?”